Enantioselective Synthesis of Epigallocatechin-3-gallate (EGCG), the Active Polyphenol Component from Green Tea
- 13 February 2001
- journal article
- letter
- Published by American Chemical Society (ACS) in Organic Letters
- Vol. 3 (5) , 739-741
- https://doi.org/10.1021/ol000394z
Abstract
Enantioselective synthesis of epigallocatechin-3-gallate (EGCG, 3b), the active polyphenol component from green tea, has been achieved by using a stereospecific cyclization of the Sharpless asymmetric dihydroxylation product 7c as the key step.Keywords
This publication has 9 references indexed in Scilit:
- Studies in Polyphenol Chemistry and Bioactivity. 1. Preparation of Building Blocks from (+)-Catechin. Procyanidin Formation. Synthesis of the Cancer Cell Growth Inhibitor, 3-O-Galloyl-(2R,3R)-epicatechin-4β,8-[3-O-galloyl-(2R,3R)-epicatechin]Journal of the American Chemical Society, 1999
- Growth inhibition of leukemic cells by (−)-epigallocatechin gallate, the main constituent of green teaLife Sciences, 1998
- Induction of apoptosis in prostate cancer cell lines by the green tea component, (−)-epigallocatechin-3-gallateCancer Letters, 1998
- Potent suppressive activity of pheophytin a and b from the non-polyphenolic fraction of green tea (Camellia sinensis) against tumor promotion in mouse skinCancer Letters, 1998
- Suppression of extracellular signals and cell proliferation through EGF receptor binding by (−)-epigallocatechin gallate in human A431 epidermoid carcinoma cellsJournal of Cellular Biochemistry, 1997
- Effect of (-)-epigallocatechin gallate on leukemic blast cells from patients with acute myeloblastic leukemiaLife Sciences, 1996
- Inhibitory effect of six green tea catechins and caffeine on the growth of four selected human tumor cell linesAnti-Cancer Drugs, 1996
- Strategy and planning for chemopreventive drug development: Clinical development plans IIJournal of Cellular Biochemistry, 1996
- Catalytic Asymmetric DihydroxylationChemical Reviews, 1994